Literature DB >> 23869667

Venous thromboembolism in pregnancy and the puerperal period: a study of 1210 events.

Rie Adser Virkus1, Ellen C L Løkkegaard, Øjvind Lidegaard, Jens Langhoff-Roos, Lars Bjerregaard, Charlotte W Skovlund, Thomas Bergholt.   

Abstract

OBJECTIVE: The aim of this study was to describe venous thromboembolism (VTE) in pregnancy and the puerperal period, and to validate diagnoses of VTE.
DESIGN: Historical cohort study. POPULATION: All pregnancies in Denmark from 1995 to 2009.
METHODS: VTE diagnoses were retrieved from national registries. MAIN OUTCOME MEASURES: Positive predictive value of a VTE diagnoses diagnosed during pregnancy or the puerperal period. Location of VTE. Incidence rate of confirmed, validated diagnoses of VTE and on all retrieved diagnoses of VTE.
RESULTS: In 1 297 037 pregnancies, 1436 women had a first-ever VTE diagnosis. Hospital records were retrieved for 1210 women (84.3%). Almost all women had relevant clinical symptoms and in 796 (65.8%), the diagnosis were confirmed by a positive diagnostic test or by instituted anticoagulation treatment. In all, 72.6, 53.7, 58.5 and 79.1% of the diagnoses were confirmed in the first, second, third trimester and the puerperal period, respectively. The 796 cases of VTE included 624 women with deep venous thrombosis only and 133 with pulmonary embolisms. Deep venous thrombosis was located in the left lower limb in 83.8% in pregnancy, compared with 67.9% in the puerperal period.
CONCLUSIONS: The vast majority of women with a registered diagnosis of VTE had relevant symptoms. Diagnoses of VTE were confirmed in the medical records in two of three women. VTE diagnoses were most often confirmed when made in the first trimester and in the puerperal period. Left-sided deep venous thrombosis was the predominant type of VTE in pregnancy and the puerperal period.
© 2013 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Incidence rate; location; pregnancy; puerperal period; validation; venous thromboembolism

Mesh:

Year:  2013        PMID: 23869667     DOI: 10.1111/aogs.12223

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

1.  Pregnancy-related venous thromboembolism and risk of occult cancer.

Authors:  Anette Tarp Hansen; Katalin Veres; Erzsébet Horváth-Puhó; Vera Ehrenstein; Paolo Prandoni; Henrik Toft Sørensen
Journal:  Blood Adv       Date:  2017-10-19

2.  When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.

Authors:  Alex J Walker; Joe West; Tim R Card; Colin Crooks; Cliona C Kirwan; Matthew J Grainge
Journal:  Blood       Date:  2015-11-16       Impact factor: 22.113

3.  Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort.

Authors:  Rie Adser Virkus; Ellen Løkkegaard; Øjvind Lidegaard; Jens Langhoff-Roos; Anne Kristine Nielsen; Kenneth J Rothman; Thomas Bergholt
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

4.  Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study.

Authors:  Duo Huang; Emmanuel Wong; Ming-Liang Zuo; Pak-Hei Chan; Wen-Sheng Yue; Hou-Xiang Hu; Ling Chen; Li-Xue Yin; Xin-Wu Cui; Ming-Xiang Wu; Xi Su; Chung-Wah Siu; Jo-Jo Hai
Journal:  Blood Res       Date:  2019-09-25

5.  Application of the RCOG Risk Assessment Model for Evaluating Postpartum Venous Thromboembolism in Chinese Women: A Case-Control Study.

Authors:  Ying-Zhou Ge; Chen Zhang; Yan-Qing Cai; He-Feng Huang
Journal:  Med Sci Monit       Date:  2021-07-07

6.  V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism.

Authors:  Marika Bajc; Berit Olsson; Anders Gottsäter; Cecilia Hindorf; Jonas Jögi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-28       Impact factor: 9.236

7.  Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort study.

Authors:  Alyshah Abdul Sultan; Joe West; Olof Stephansson; Matthew J Grainge; Laila J Tata; Kate M Fleming; David Humes; Jonas F Ludvigsson
Journal:  BMJ Open       Date:  2015-11-11       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.